
About Nextone Pharmaceuticals Private Limited
Data last updated:
Nextone Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 23 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51909UP2020PTC135071. Its GSTIN is 09AAHCN1903D1ZS (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Dhirender Kumar Tripathi and Durgesh Kumar Tripathi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 3 Kh. No. 257 And 258 GF, Vinayak City Indira Nagar Lucknow/Lesa, Uttar Pradesh, India – 226016.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.5 Lakh, a growth of 65% compared to the previous year. For the same year it recorded a net profit of ₹45,584 (net margin 3.4%) and EBITDA of ₹80,859 (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 107% over three years.
The company is associated with 1 brand: NEXTONE Pharmaceuticals.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nextonepharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. 3 Kh. No. 257 And 258 GF, Vinayak City Indira Nagar Lucknow/Lesa, Uttar Pradesh, India – 226016
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nextone Pharmaceuticals Private Limited
The main business activity of Nextone Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nextone Pharmaceuticals Private Limited FY 2024 filings available
Nextone Pharmaceuticals Private Limited reported revenue of ₹13.5 Lakh (up 65% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Nextone Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 107% over three years, including 65% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nextone Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹80,859 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹45,584 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Nextone Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6% | •••• | •••• | •••• |
| Net Profit Margin | 3.4% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nextone Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nextone Pharmaceuticals Private Limited
Nextone Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dr. CSW Pharmaceuticals Private Limited | ₹13.67 Lakh (FY 2023) | •••• | •••• | 36.0% | •••• | Akola, Maharashtra, India |
| Maxkos Pharmaceuticals Private Limited | ₹13.63 Lakh (FY 2025) | •••• | •••• | -65.0% | •••• | Solapur, Maharashtra, India |
| Ryokona Pharmaceuticals Private Limited | ₹13.59 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Sangie Pharmaceuticals Private Limited | ₹13.57 Lakh (FY 2025) | •••• | •••• | -80.0% | •••• | Thane, Maharashtra, India |
| Miron Pharmaceuticals Private Limited | ₹13.5 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Nellore, Andhra Pradesh, India |
| Nextone Pharmaceuticals Private Limited this company | ₹13.5 Lakh (FY 2024) | •••• | •••• | 65.0% | •••• | Lucknow, Uttar Pradesh, India |
| P.G.H Pharmaceuticals India Private Limited | ₹13.49 Lakh (FY 2025) | •••• | •••• | -16.0% | •••• | Mathura, Uttar Pradesh, India |
| Shamrax Pharmaceuticals Private Limited | ₹13.45 Lakh (FY 2025) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Astrio Pharmaceuticals Private Limited | ₹13.45 Lakh (FY 2020) | •••• | •••• | •••• | Katrap, Maharashtra, India | |
| Archimed Pharmaceuticals Private Limited | ₹13.4 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Bareilly, Uttar Pradesh, India |
| Shasha Pharmaceuticals Private Limited | ₹13.39 Lakh (FY 2025) | •••• | •••• | 128.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Nextone Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Nextone Pharmaceuticals Private Limited
Nextone Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhirender Kumar Tripathi | Director | 23 Sep 2020 | 6 Years 0 Months | Current |
| Durgesh Kumar Tripathi | Director | 23 Sep 2020 | 6 Years 0 Months | Current |
Ownership and Shareholding of Nextone Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nextone Pharmaceuticals Private Limited
Nextone Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Nextone Pharmaceuticals Private Limited
Nextone Pharmaceuticals operates one associated brand: NEXTONE Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution in healthcare segments. | nextonepharmaceuticals.com |
Employees and EPFO Compliance at Nextone Pharmaceuticals Private Limited
Nextone Pharmaceuticals Private Limited has a workforce of 0 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nextone Pharmaceuticals Private Limited
Nextone Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Dhirender Kumar Tripathi was appointed as Director on 23 Sep 2020.
Credit Ratings, Litigation & Regulatory Alerts for Nextone Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nextone Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nextone Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nextone Pharmaceuticals Private Limited
Nextone Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCN1903D1ZS | Uttar Pradesh | Active | 12 Oct 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nextone Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nextone Pharmaceuticals Private Limited
Nextone Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 23 September 2020 (6+ years old) and is registered under CIN U51909UP2020PTC135071.
Nextone Pharmaceuticals reported revenue of ₹13.5 Lakh for FY 2024 (up 65% YoY).
Nextone Pharmaceuticals has 2 current directors:
- Dhirender Kumar Tripathi - Director
- Durgesh Kumar Tripathi - Director
Nextone Pharmaceuticals reported a net profit of ₹45,584 (net margin 3.4%) and EBITDA of ₹80,859 (EBITDA margin 6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nextone Pharmaceuticals is 107% over three years. In the latest year (FY 2024) revenue rose 65%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nextone Pharmaceuticals is 09AAHCN1903D1ZS, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Nextone Pharmaceuticals is U51909UP2020PTC135071. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nextone Pharmaceuticals was incorporated on 23 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Nextone Pharmaceuticals by revenue are Dr. CSW Pharmaceuticals Private Limited, Maxkos Pharmaceuticals Private Limited, Ryokona Pharmaceuticals Private Limited, Sangie Pharmaceuticals Private Limited, Miron Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Dhirender Kumar Tripathi was appointed as Director on 23 Sep 2020. Durgesh Kumar Tripathi was appointed as Director on 23 Sep 2020.
Yes, Nextone Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).